SEARCH

SEARCH BY CITATION

References

  • 1
    Chang CH, Horton J, Schoenfeld D et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 1983; 52: 9971007.
  • 2
    Eyre HJ, Quagliana JM, Eltringham JR et al. Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery. J Neurooncol 1983; 1: 171177.
  • 3
    Solero CL, Monfardini S, Brambilla C et al. Controlled study with BCNU versus CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme. Cancer Clin Trials 1979; 2: 4348.
  • 4
    Paoletti P, Robustelli della Cuna G, Knerich R, Strada MR. Multidisciplinary treatment for central nervous system tumours with nitrosourea compounds. Acta Neurochirurgica 1978; 41: 287299.
  • 5
    Reagan TJ, Bisel HF, Childs DS Jr, Layton DD, Rhoton AL Jr, Taylor WF. Controlled study of CCNU and radiation therapy in malignant astrocytoma. J Neurosurg 1976; 44: 186190.
  • 6
    Stewart DJ, Wallace S, Feun L et al. A phase I study of intracarotid artery infusion of cis-diamminedichloroplatinum (II) in patients with recurrent malignant intracerebral tumors. Cancer Res 1982; 42: 20592062.
  • 7
    Feun LG, Wallace S, Stewart DJ et al. Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors. Cancer 1984; 54: 794799.
  • 8
    Madajewicz S, West CR, Tyson G et al. Intra-carotic/vertebral chemotherapy (ICC) of high grade astrocytomas (HGA) and metastatic brain tumor (MBT): Evaluation of regional approach and different agents (Abstr). J Cancer Res Clin Oncol 1990; 116: 408.
  • 9
    Greenburg HS, Ensminger WD, Chandler WF et al. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system. J Neurosurg 1984; 61: 423429.
  • 10
    Shani J, Bertram J, Russell C et al. Noninvasive monitoring of drug biodistribution and metabolism: Studies with intraarterial Pt-195m-cisplatin in humans. Cancer Res 1989; 49: 18771881.
  • 11
    Stewart DJ, Leavens M, Maor M et al. Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 1982; 42: 24742479.
  • 12
    Lehane D, Ehni G, Moiel R et al. Adjuvant therapy for malignant gliomas (MG) using intra-arterial (IA) cis-platinum (CP), radiation therapy (RT) and CCNU (Abstr). Proc Am Soc Clin Oncol 1983; 236.
  • 13
    Alverez MV, Cobreros G, Heras A, Zumel MC Lopez. Studies of cis-dichlorodiammineplatinum (II) as a radiosensitizer. Br J Cancer 1978; (Suppl 3) 37: 6872.
  • 14
    Dritschilo A, Piro AJ, Kelman AD. The effect of cis-platinum on the repair of radiation damage in plateau phase Chinese hamster (V-79) cells. Int J Radiat Oncol Biol Phys 1979; 5: 13451349.
  • 15
    Murthy AK, Rossof AH, Anderson KM, Hendrickson FR. Cytotoxicity and influence on radiation dose response curve of cis-diamminedichloro-platinum II (cis-DDP). Int J Radiat Oncol Biol Phys 1979; 5: 14111415.
  • 16
    Wile AG, Kar R, Cohen RA, Jakowatz JG, Opfell RW. The pharmacokinetics of cisplatin in experimental regional chemotherapy. Cancer 1987; 59: 695700.
  • 17
    Ozols RF, Corden BJ, Jacob J, Wesley MN, Ostchega Y, Young RC. High-dose cisplatin in hypertonic saline. Ann Intern Med 1984; 100: 1924.
  • 18
    Barker GH, Wiltshaw E. Use of high dose cis-dichlorodiammine platinum (II) (NSC-119875) following failure on previous chemotherapy for advanced carcinoma of the ovary. Br J Obstet Gynaecol 1981; 88: 11921199.
  • 19
    Newton HB, Page MA, Junck L, Greenberg HS. Intra-arterial cisplatin for the treatment of malignant gliomas. J Neurooncol 1989; 7: 3945.
  • 20
    Feun LG, Wallace S, Stewart DJ et al. Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors. Cancer 1984; 54: 794799.
  • 21
    Mahaley MS Jr, Hipp SW, Dropcho EJ et al. Intracarotid cisplatin chemotherapy for recurrent gliomas. J Neurosurg 1989; 70: 371378.